1. Articles in category: Other Business News

    937-960 of 1056 « 1 2 ... 37 38 39 40 41 42 43 44 »
    1. Intravascular Ultrasound (IVUS) Market: An Analysis -- IVUS market is the fastest growing segment of interventional cardiology

      The report analyzes the IVUS market looking at the market from global as well as regional perspective. The various market related factors are being interpreted either as market drivers or market limiters. IVUS market is the fastest growing segment of interventional cardiology. IVUS is primarily used during the stenting procedure in the percutaneous coronary intervention (PCI). The growth in this market is mainly based on the number of PCI procedures and stenting procedures or the stenting placements. More the stents being used, more would be the need of IVUS technology.
      Read Full Article
    2. Market Scope Expects Retina Pharmaceutical Industry to Top $3.5 Billion by 2014

      Advances in diagnostic equipment have laid the groundwork for better diagnosis and monitoring of retinal disease. This is most evident in the new optical coherence technology (OCT) devices that have dramatically improved image resolution and provided real-time cross-sectional images of retinal tissues. Carl Zeiss, Heidelberg, Topcon and Optovue are currently the lead competitors in the rapidly expanding OCT market. Despite tight capital budgets, Market Scope expects growing demand for retinal care and new diagnostic technologies to result in a compounded annual growth of 6.4 percent in the retinal diagnostic equipment segment over the next five years.
      Read Full Article
    3. Optical Coherence Tomography (OCT) Presentations by Volcano at EuroPCR 2009

      Optical Coherence Tomography (OCT) Presentations by Volcano at EuroPCR 2009
      May 19, 2009 -- San Diego and Barcelona -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis of coronary and peripheral artery disease, today highlights its technology leadership position in the emerging field of Optical Coherence Tomography (OCT) at the EuroPCR conference in Barcelona, Spain.
      Read Full Article
    4. Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents

      Angiographic and optical coherence tomography (OCT) imagery were reviewed illustrating the new stent platform's deliverability, design features, and vessel scaffolding. "The nature of the polymeric materials allows for tremendous innovation in stent ...
      Read Full Article
    5. Volcano Announces OCT Activities at EuroPCR 2009

      Volcano's Axsun Laser - At the Heart of OCT SAN DIEGO and BARCELONA, Spain, May 19 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis of coronary and peripheral artery disease, today highlights its technology leadership position in the emerging field of Optical Coherence Tomography (OCT) at the EuroPCR conference in Barcelona, Spain. Volcano's wholly owne
      Read Full Article
    6. Volcano Announces Worldwide Exclusive Distribution Agreement With Lumen Biomedical for Xtract(TM) Thrombus Aspiration Catheter

      SAN DIEGO, May 18 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today announced an exclusive worldwide distribution agreement to initiate the formal launch of the Xtract(TM) thrombus aspiration catheter, manufactured by Lumen Biomedical. The Xtract(TM) thrombus aspiration catheter is available for immediate sale in the U.S. and Europe. This marks Volcano's entry into what we believe is a $70+ million aspiration market.
      Read Full Article
    7. Volcano Corporation Presentation at JMP Conference to be Webcast

      SAN DIEGO, May 12, 2009 - Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the Eighth Annual JMP Securities Research Conference on Monday, May 18.
      Read Full Article
    8. Volcano Corp Q1 2009 Earnings Call Transcript

      As we reported in 10-K for 2008, the Superior Court in Massachusetts in January issued a preliminary adjunction against Axsun and Volcano in response to a complaints filled by LightLab, a wholly owned subsidiary of Goodman. The initial injunction prohibited Volcano from using Axsun tunable lasers and Volcano's OCT products under development, but ordered a full hearing following a more complete discovery. We are pleased to report that as a results of the full hearing that occurred in March, the trial court reconsider the broad injunction and issued a much more limited order to provide simply that a) Axsun ...
      Read Full Article
    9. Volcano Reports First Quarter Revenues of $49.0 Million; IVUS and FM Businesses Grew 24 Percent

      The revenues for the first quarter of 2009 include $3.7 million from Axsun Technologies, Inc., which Volcano acquired at the end of 2008 and for which the company recorded no revenues in the first quarter a year ago. The company said revenue growth was ...
      Read Full Article
    10. Near Infrared Optical Coherence Tomography (OCT) Solutions: Pembroke Instruments SD-OCT Engine Product

      Near Infrared Optical Coherence Tomography (OCT) Solutions: Pembroke Instruments SD-OCT Engine Product
      BaySpec’s all new DeepViewTM Fourier or Spectral-Domain (SD) OCT Spectral Engine is compatible with a variety of high speed digital line scan cameras enabling simultaneous coverage of multiple wavelengths for precise and rapid OCT measurements. The DeepViewTM Spectral Engine provides convenience for researchers and OEM users assembling spectral-domain optical coherence tomography (SD-OCT), white light interferometry (WLI) or VIS-NIR spectroscopy systems. This flat-field spectral analyzer design is based on highly efficient transmission Volume Phase Grating (VPG) and is compatible with a variety of digital line scan cameras covering the wide wavelength ranges. The spectral engine can be configured for various ...
      Read Full Article
    11. Volcano Corporation Schedules First Quarter Conference Call, Webcast

      SAN DIEGO, April 27 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today announced that it will report its operating results for the first quarter of fiscal 2009 on Tuesday, May 5. The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 2 p.m., Pacific Daylight Time (5 p.m., Eastern Daylight Time), Tuesday, May 5, hosted by Scott Huennekens, president and chief executive officer, and John Dahldorf, chief financial ...
      Read Full Article
    12. NineSigma, representing a global device manufacturer, invites proposals for the development of a low cost tunable light source for optical coherence reflectometry.

      NineSigma, representing a global device manufacturer, invites proposals for the development of a low cost tunable light source for optical coherence reflectometry.
      NineSigma, representing a global device manufacturer, invites proposals for the development of a low cost tunable light source for optical coherence reflectometry. The successful technology must provide a cost efficient swept source module for optical coherence domain reflectometry. The purchase of a working prototype is the preferred solution but final development of a mature concept is possible.
      Read Full Article
    13. Cardiac imaging and OCT's legal mess

      "Word is getting out” about imaging tools that enable more precise guidance during heart surgery, said Volcano Corp. VP Joe Burnett, referring to the increased number of imaging-related presentations at the recent American College of Cardiology (ACC) Annual Meeting 2009.) Speaking at the conference, former ACC President Pamela Douglas, M.D. said that imaging is growing faster than all other procedures, services and diagnostic tests
      Read Full Article
    14. Lantis Files 15(c) 2-11 With Finra to Obtain Listing On OTC Bulletin Board

      DENVILLE, N.J., April 1, 2009 (GLOBE NEWSWIRE) -- Lantis Laser Inc. (Pink Sheets:LLSR) (http://www.lantislaser.com), announced today that it has filed a 15(c) 2-11 with FINRA to obtain a quotation on the OTC Bulletin Board. Stan Baron, President & CEO, pointed out that being a fully reporting company will provide the transparency and credibility that investors require in today's economic environment. Lantis filed an S-1 with the SEC which was deemed effective on February 17, 2009.
      Read Full Article
    15. Volcano Announces Schedule of Events at the ACC 2009, Integration into Indec and Medis Software Platforms

      Volcano Announces Schedule of Events at the ACC 2009, Integration into Indec and Medis Software Platforms
      March 27, 2009 -- San Diego -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today announced its presence at the 58th Annual Scientific Sessions of the American College of Cardiology (ACC) conference in Orlando, FL, to be held from March 29th to 31st, 2009. Joe Burnett, Vice President of Marketing at Volcano commented, "Three years ago, you could flip through the ACC program and see a couple of presentations on intravascular assessment using IVUS or FFR. This year, there are more than 50 presentations ...
      Read Full Article
    16. Medical venture - Michelson Diagnostics

      Medical venture - Michelson Diagnostics
      Orpington-based medical-imaging firm Michelson Diagnostics (MDL) has raised more than £350k from a consortium of investors from the London Business Angels (LBA) network. The money will be used to support multi-centre clinical trials of its new hand-held multi-beam Optical Coherence Tomography (OCT) imaging probe, which the company plans to launch in May or June this year.
      Read Full Article
    17. Medical Venture - Michelson Diagnostics (MDL)

      Orpington-based medical-imaging firm Michelson Diagnostics (MDL) has raised more than £350k from a consortium of investors from the London Business Angels (LBA) network. The money will be used to support multi-centre clinical trials of its new hand-held multi-beam Optical Coherence Tomography (OCT) imaging probe, which the company plans to launch in May or June this year. The money will also support international commercial growth. MDL received early-stage funding of £600k in October 2007 and a further £600k in July 2008, in rounds led by London Seed Capital with Catapult Venture Managers and London Business Angels.
      Read Full Article
    18. Lantis Signs Exclusive Rights in Dentistry for Novel Light-Based Diagnostic Screening Technology

      Near-infrared Transillumination Imaging Provides More Detailed Images Than X-ray. DENVILLE, N.J., Mar 17, 2009 (GlobeNewswire via COMTEX) -- Lantis Laser Inc. (Pink Sheets:LLSR) ( http://www.lantislaser.com) today announced that it has signed an exclusive Agreement for the field of human and animal dentistry with the Regents of the University of California for a light-based technology referred to as "Near-infrared Transillumination Imaging of Early Dental Decay." The technology ("NIR Imaging") is the subject of a PCT patent pending application and was researched and developed over the past five years under the direction of Daniel Fried, PhD, a professor of ...
      Read Full Article
    19. Lantis Signs Exclusive Rights in Dentistry for Novel Light-Based Diagnostic Screening Technology

      Lantis Signs Exclusive Rights in Dentistry for Novel Light-Based Diagnostic Screening Technology
      DENVILLE, N.J., March 17, 2009 (GLOBE NEWSWIRE) -- Lantis Laser Inc. (Other OTC:LLSR.PK - News) (http://www.lantislaser.com) today announced that it has signed an exclusive Agreement for the field of human and animal dentistry with the Regents of the University of California for a light-based technology referred to as ``Near-infrared Transillumination Imaging of Early Dental Decay.'' The technology (``NIR Imaging'') is the subject of a PCT patent pending application and was researched and developed over the past five years under the direction of Daniel Fried, PhD, a professor of Biomaterials and Bioengineering in the Department of Preventive ...
      Read Full Article
    20. Lightlab Imaging, Axsun Technologies, and Volcano Corporation in Legal Dispute

      Lightlab Imaging, Axsun Technologies, and Volcano Corporation in Legal Dispute
      Volcano Corporation's recent Securities and Exchange Commission 10-k filing announced a suit by Lightlab Imaging against Axsun Technologies and Volcano Corporation. Some background information that may be relevant to this court case: On January 7, 2009 Lightlab Imaging filed suit against Axsun Technologies and Volcano Corporation in the Business Litigation Section of the Superior Court of Massachusetts. On December 10, 2007, Volcano, a leading supplier in Intravascular Ultrasound (IVUS) equipment acquired startup company CardioSpectra for ~$55M ($25M plus an additional ~$30M earnout). According to the press release, "CardioSpectra's unique OCT imaging system is expected to complement Volcano's ...
      Read Full Article
    21. Volcano & Axsun Sued by Lightlab Imaging

      Volcano & Axsun Sued by Lightlab Imaging
      On January 7, 2009, LightLab Imaging Inc., or LightLab, filed a complaint against Volcano and its wholly-owned subsidiary, Axsun, in the Superior Court of Massachusetts, Suffolk County, seeking injunctive relief and unspecified damages. LightLab’s complaint alleges that Volcano interfered with LightLab’s development and supply agreement with Axsun and its advantageous business relationship with Axsun, engaged in unfair competition, engaged in unfair or deceptive acts or practices and engaged in misappropriation and wrongful use of LightLab’s confidential information and trade secrets. LightLab’s complaint alleges that Axsun breached its development and supply agreement with LightLab, breached the implied ...
      Read Full Article
    937-960 of 1056 « 1 2 ... 37 38 39 40 41 42 43 44 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Popular Articles

  3. Organizations in the News

    1. (1 articles) FDA
  4. People in the News

    1. (1 articles) Christian Velez
    2. (1 articles) Marcus Duelk
  5. OCT Companies in the News

    1. (1 articles) Topcon Medical Systems
    2. (1 articles) Exalos
    3. (1 articles) Mirrorcle Technologies
    4. (1 articles) Teledyne SP Devices